Malignant pleural effusion (MPE) is a serious complication of advanced tumor, with relatively
high morbidity and mortality rates, and can severely affect the quality of life and survival of …

Malignant pleural effusions (MPE) have historically been associated with a poor prognosis,
and patients often require a series of invasive procedures and hospitalizations that …

Background Pleurodesis is done as an in-patient procedure to control symptomatic recurrent
malignant pleural effusion (MPE) and has a success rate of 75–80%. Thoracic …

Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic
malignancies and is associated with high mortality. Treatment is mainly palliative, with …

Rationale: Recent trends in the care and outcomes of pleural infection are not well
characterized. Objectives: To investigate trends in hospital-based healthcare use, outcomes …

Pleural diseases include a spectrum of disorders broadly categorized into pneumothorax
and pleural effusion. They often cause pain, breathlessness, cough, and reduced quality of …

Objectives Recurrent symptomatic effusions can be durably managed with pleurodesis or
placement of indwelling pleural catheters. Recent pleurodesis trials have largely relied on …

Background: A well-recognized therapy to improve the symptoms of patients with malignant
pleural effusion (MPE), indwelling pleural catheters (IPCs) can also achieve spontaneous …

Ein maligner Pleuraerguss (MPE) ist eine häufige Komplikation von thorakalen und
extrathorakalen Malignomen und geht mit einer hohen Sterblichkeit einher. Die Behandlung …

Rising healthcare costs make access to healthcare less accessible for many individuals.
Hospital administrators, payer stakeholders, and patients are concerned with rising …